GKN2 and pancreatic intraductal papillary-mucinous neoplasm: Interestingly, GKN2 was one of the most upregulated genes in the IPMN-derived cohort, which is in line with the literature suggesting that IPMN-derived PDAC patients have longer survival times, possibly due to earlier diagnosis [53,54].